biotech Β· PTSD - Post Traumatic Stress Disorder Β· P1b: Advanced Solid Tumors Β· CMPX
Compass Therapeutics
Compass Therapeutics trial registry β 23 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 80 Guest Street, Suite 601, Boston, MA 02135, US
- Founded
- 2014
- Employees
- 54
- Programs
- 15
- Drugs
- 3
- Patents
- 100
Compass Therapeutics clinical trials
Registry index of 23 ClinicalTrials.gov studies linked to Compass Therapeutics programs β each row shows trial ID, program name, phase, status, and indication.
Compass Therapeutics trial registry β 23 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Compass Therapeutics.
-
Psilocybin β Phase 2
Clinical update -
Psilocybin β Phase 3
Clinical update -
CTX-10726 β Phase 1
Clinical update -
COMP360 psilocybin β Phase 3
Clinical update -
CTX-009 β Phase 3
Clinical update -
Psilocybin β Phase 3
Clinical update -
CTX-009 β Phase 2
Clinical update -
CTX-009 β Phase 2
Clinical update